Michael Singer, MD, PhD, is a serial entrepreneur, investor, and ophthalmologist. He has co-founded several life sciences companies, including HealthHonors (sold to Healthways in 2009) and Topokine (sold to Allergan in 2016). Most recently he co-founded Cartesian Therapeutics, a clinical-stage company developing a new generation of Chimeric Antigen Receptor T-cell (CAR-T) products. Mike is also a registered patent agent. He is named as inventor on over 100 issued patents and has written over 25 peer-reviewed scientific papers. Mike completed his B.S. in Biology, Ph.D. in Neuroscience, and M.D. at Yale, followed by internship and residency at Harvard.
Education & Training
- MDYale School of Medicine (2002)
- PhDYale School of Medicine, Neuroscience (2000)
- BS (Hon)Yale College, Biology (1995)